Last reviewed · How we verify

SUCROSE — Competitive Intelligence Brief

SUCROSE (SUCROSE) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Parenteral Iron Replacement [EPC].

marketed Parenteral Iron Replacement [EPC] Small molecule Live · refreshed every 30 min

Target snapshot

SUCROSE (SUCROSE).

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
SUCROSE TARGET SUCROSE marketed Parenteral Iron Replacement [EPC]
Feraheme FERUMOXYTOL Covis marketed Parenteral Iron Replacement [EPC] 2009-01-01
IRON SUCROSE IRON SUCROSE marketed Parenteral Iron Replacement [EPC] 2000-01-01
Sodium Ferric Gluconate Complex in Sucrose. Sodium Ferric Gluconate Complex in Sucrose. Watson Pharmaceuticals marketed Parenteral Iron Replacement [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Parenteral Iron Replacement [EPC] class)

  1. · 2 drugs in this class
  2. Covis · 1 drug in this class
  3. Watson Pharmaceuticals · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SUCROSE — Competitive Intelligence Brief. https://druglandscape.com/ci/sucrose. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: